Your browser doesn't support javascript.
loading
Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
Meehan, James; Ward, Carol; Turnbull, Arran; Bukowski-Wills, Jimi; Finch, Andrew J; Jarman, Edward J; Xintaropoulou, Chrysi; Martinez-Perez, Carlos; Gray, Mark; Pearson, Matthew; Mullen, Peter; Supuran, Claudiu T; Carta, Fabrizio; Harrison, David J; Kunkler, Ian H; Langdon, Simon P.
Affiliation
  • Meehan J; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Ward C; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Turnbull A; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Bukowski-Wills J; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Finch AJ; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Jarman EJ; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Xintaropoulou C; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Martinez-Perez C; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Gray M; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Pearson M; IGMM Advanced Imaging Resource, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Mullen P; School of Medicine, University of St Andrews, Fife KY16 9TF, United Kingdom.
  • Supuran CT; Department of Neurofarba, Sez. Chimica Farmaceutica e Nutraceutica, University of Florence, 50019-Sesto Fiorentino, Italy.
  • Carta F; Department of Neurofarba, Sez. Chimica Farmaceutica e Nutraceutica, University of Florence, 50019-Sesto Fiorentino, Italy.
  • Harrison DJ; School of Medicine, University of St Andrews, Fife KY16 9TF, United Kingdom.
  • Kunkler IH; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
  • Langdon SP; Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
Oncotarget ; 8(26): 42857-42875, 2017 Jun 27.
Article in En | MEDLINE | ID: mdl-28476026
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Hydrogen-Ion Concentration / Hypoxia Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Hydrogen-Ion Concentration / Hypoxia Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States